Safety and Efficacy of Neoadjuvant Immune Checkpoint Inhibitor Therapy in Patients with Resectable Non-small-Cell Lung Cancer: A Systematic Review
Ziran Zhao, Yibo Gao, Qi Xue, Shugeng Gao, Jie He
Topics & Concepts
MedicineNivolumabDurvalumabAtezolizumabPembrolizumabInternal medicineIpilimumabOncologyLung cancerAdverse effectAvelumabCancerNeoadjuvant therapyImmunotherapyBreast cancerCancer Immunotherapy and BiomarkersLung Cancer Diagnosis and TreatmentLung Cancer Research Studies